Phase 2 Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Phase II Study of RC1416 Injection in COPD
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.180 enrolled41 locationsNCT07402551
Recruiting
Phase 1Phase 2
cfMSC Stem Cell Therapy Targeting COPD
Chronic Obstructive Pulmonary Disease (COPD)
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT07477600
Recruiting
Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca1,160 enrolled363 locationsNCT07082738
Recruiting
Phase 2
Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients
Chronic Obstructive Pulmonary Disease (COPD)
RSUP Persahabatan20 enrolled1 locationNCT07441226
Recruiting
Phase 2
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Chronic Obstructive Pulmonary Disease (COPD)Allergies
Johns Hopkins University334 enrolled23 locationsNCT07059091
Completed
Phase 2
Ginseng extract for patients with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
RMIT University200 enrolled1 locationACTRN12613000382774
Recruiting
Phase 2
Inhaled verapamil in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease (COPD)
Pulmonary hypertension secondary to chronic obstructive pulmonary disease (COPD)
Shahid Beheshti University, M.C.30 enrolled1 locationACTRN12612001239853
Completed
Phase 2
A Phase 2, Randomized, Double-Blind, Multiple-Dose, Five-Period, Incomplete-Block, Crossover Study to Examine the Pharmacodynamics, Safety and Tolerability, and Pharmacokinetics of Multiple Doses of TD-4208 for 7 Days in Subjects Diagnosed With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Theravance Biopharma R & D, Inc.60 enrolled2 locationsACTRN12612001235897
Completed
Phase 2
A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Single-Season Study to Assess the Efficacy and Safety of HI-164OV Oral Vaccine in Moderate to Severe chronic obstructive pulmonary disease (COPD).
Chronic Obstructive Pulmonary Disease (COPD)
Hunter Immunology Limited340 enrolled1 locationACTRN12610000916044
Completed
Phase 2
Ginseng extract for patients with moderate Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Royal Melbourne Institute of Technology (RMIT) University168 enrolled1 locationACTRN12610000768099